Design and Evaluation of Nanoparticulate Drug Delivery Systems for Imaging and Treatment of Malignant Brain Tumor

Minyahil A. Woldu; Jimma Likisa Lenjissa; Gizaw Dabessa Satessa

Authors

Minyahil A. Woldu
Jimma Likisa Lenjissa
Gizaw Dabessa Satessa

nanoparticulate, nanoparticle, nanovectors, nanomedicine, nanoparticulate drug delivery system

Abstract

Malignant brain tumours are one of the most devastating human cancers associated with high mortality and morbidity rates. The median survival of malignant glioma patie-nts ranges between 3 and 16 months and has virtually rema-ined unchanged during the last 3 decades. Difficulties in early detection, local recurrence, and resistance to conventional therapies are the major reasons for failure in malignant brain tumour treatment. The therapy of malignant gliomas is further limited by the inadequate delivery of therapeutic agents to the brain due to the presence of the blood-brain barrier, blood-brain-tumor barrier as well as non-specificity targeting. Nanoparticles (NPs) have drawn increased interest in treating malignant brain tumours due to their potential to act as a vector for brain delivery and to provide tumourspecific detection and treatment. If designed appropriately, NPs may act as a drug vehicle able to target tumor tissues or cells, and protect the drug from inactivation during its transport. The aim of this article was to provide brief overview of nanoparticulate drug delivery systems for imaging and treatment of brain cancer and to evaluate their safety in clinical use. Besides invasive physical methods to bypass or disrupt the BBB and/or BBTB, other methods like pharmacological and physio-logic approach are possible.

Downloads

How to Cite

Design and Evaluation of Nanoparticulate Drug Delivery Systems for Imaging and Treatment of Malignant Brain Tumor. (2014). Global Journal of Science Frontier Research, 14(8), 15-25. https://journalofscience.org/index.php/GJSFR/article/view/

Download Citation

References

Alessandra Pavesio (2006) Regenerative Medicine.

C. Hadjipanayis, A. Bouras, S. Chang (2013) Applications of Multifunctional Nanoparticles in Malignant Brain Tumours. EUR ASSOC NEUROONCOL MAG. 1-7.

Yu Cheng, Ramin Morshed, Brenda Auffinger, Alex Tobias, Maciej Lesniak (2013) Multifunctional nanoparticles for brain tumor imaging and therapy. 66, 42-57. https://doi.org/10.1016/j.addr.2013.09.006

Chih-hsien Gann ting, Hsin-ell wang (2009) Cancer Nanotargeted Radiopharmaceuticals for Tumor Imaging and Therapy. 29, 4107-4118.

L. Muldoon, P. Tratnyek, P. Jacobs, N. Doolittle, G. Christoforidis (2006) Imaging and Nanomedicine for Diagnosis and Therapy in the Central Nervous System: Report of the Eleventh Annual Blood-Brain Barrier Disruption Consortium Meeting. 27, 715-721.

Tennyson Joseph D Meyers, Clemens Doane, James Burda, Basilion (2013) Nanoparticles for imaging and treating brain cancer. 8, 123-143.

M. Amiji (2006) Nanotechnology for Cancer Therapy; Amiji DMM.

Natalie Praetorius, Tarun Mandal (2007) Engineered Nanoparticles in Cancer Therapy. 1(1), 37-51. https://doi.org/10.2174/187221107779814104

Juillerat-Jeanneret L (2008) The targeted delivery of cancer drugs across the blood-brain barrier: chemical modifications of drugs or drugnanoparticles?. 13, 1099-1106.

S. Moghimi, A. Hunter, J. Murray (2005) Nanomedicine: current status and future prospects. 19(3), 311-330. https://doi.org/10.1096/fj.04-2747rev

Loredana Serpe (2006) Conventional Chemotherapeutic Drug Nanoparticles for Cancer Treatment. https://doi.org/10.1002/9783527610419.ntls0060

Ranendra Saha, Sekar Vasanthakumar, Girish Bende, Movva Snehalatha (2010) Nanoparticulate drug delivery systems for cancer chemotherapy. 27(7), 215-231. https://doi.org/10.3109/09687688.2010.510804

Frank Alexis, Eric Pridgen, Robert Langer, Omid Farokhzad (2010) Drug Delivery: Nanoparticle Technologies for Cancer Therapy. 55-86. https://doi.org/10.1007/978-3-642-00477-3

Y. Pathak (2009) Recent Developments in Nanoparticulate Drug Delivery Systems. In: Yashwant Pathak, Deepak Thassu, editors. Drug Delivery Nanoparticles Formulation and Characterization. NY: Informa Healthcare USA. 1-15.

A. Guyton, Je (2005) Textbook of Medical Physiology.

Massimo Masserini (2013) Nanoparticles for Brain Drug Delivery. 2013, 1-18.

Sarin H, Kanevsky AS, Wu H, Brimacombe KR, Fung SA (2008) Effective transvascular delivery of nanoparticles across the blood-brain tumor barrier into malignant glioma cells. 6(1), 80. https://doi.org/10.1186/1479-5876-6-80

F. Giulio, Lawrence Paciotti, Tamarkin (2007) Nanoparticulate Drug Delivery Systems; Deepak Thassu, Michel Deleers, Pathak Y.

(SCENIHR) SCoEaNIHR (2006) the appropriateness of existing methodologies to assess the potential risks associated with engineered and adventitious products of nanotechnologies.

Amrita Dikpati, Madgulkar, J. Sanjay, Kshirsagar, Bhalekar, Chahal, AS (2012) Targeted Drug Delivery to CNS using Nanoparticles. 2.

K. Swatantra, Aditi Kushwaha, A. RastogI, Satyawan Rai, Singh (2012) Novel Drug Delivery System for Anticancer Drug. 4, 542-553.

Xiaobin Wu, Robert Zhao, Lee (2007) Lipid-Based Nanoparticulate Drug Delivery Systems. 92.

Oktay Tacar, Pornsak Sriamornsak, Crispin Dass (2013) Doxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systems. 65(2), 157-170. https://doi.org/10.1111/j.2042-7158.2012.01567.x

Regulon (2009) BBB (blood‐brain barrier).

Gelperina SE, Khalansky AS, Skidan IN, Smirnova ZS, Bobruskin AI (2002) Toxicological studies of doxorubicin bound to polysorbate 80-coated poly(butyl cyanoacrylate) nanoparticles in healthy rats and rats with intracranial glioblastoma. 126(2), 131-141. https://doi.org/10.1016/s0378-4274(01)00456-8

Jörg Kreuter (2001) Nanoparticulate systems for brain delivery of drugs. 47(1), 65-81. https://doi.org/10.1016/s0169-409x(00)00122-8

Nazila Kamaly, Zeyu Xiao, Pedro Valencia, Aleksandar Radovic-Moreno, Omid Farokhzad (2011) Targeted polymeric therapeutic nanoparticles: design, development and clinical translation. 41(7), 2971. https://doi.org/10.1039/c2cs15344k

Bärbel Volker Wagner, Sibylle Gaisser, anne-Katrin Bock (2006) Nanomedicine: Drivers for development and possible impacts Luxembourg: European Commission Joint Research Centre Institute for Prospective Technological Studies.

Ernest Azzopardi, Elaine Ferguson, David Thomas (2013) The enhanced permeability retention effect: a new paradigm for drug targeting in infection. 68(2), 257-274. https://doi.org/10.1093/jac/dks379

H. Choi, W. Liu, P. Misra, E. Tanaka, J. Zimmer (2007) Renal clearance of quantum dots. 25, 1165-1170.

Pathak Y, Thassu D, Deleers M (2007) Pharmaceutical Applications of Nanoparticulate Drug-Delivery Systems. In: Thassu D, Deleers M, Pathak Y, editors. Nanoparticulate Drug Delivery Systems. NY: Informa Healthcare USA. 185-212.

Costantino L, D. B (2012) Review Is there a clinical future for polymeric nanoparticles as brain-targeting drug delivery agents?. 17(7-8), 367-378. https://doi.org/10.1016/j.drudis.2011.10.028

He H, Li Y, Jia XR, Du J, Ying X (2011) PEGylated Poly(amidoamine) dendrimer-based dual-targeting carrier for treating brain tumors. 32(2), 478-487. https://doi.org/10.1016/j.biomaterials.2010.09.002

Yan H, Wang L, Wang J, Weng X, Lei H (2012) Two-Order Targeted Brain Tumor Imaging by Using an Optical/Paramagnetic Nanoprobe across the Blood Brain Barrier. 6(1), 410-420. https://doi.org/10.1021/nn203749v

Letfullin RR, Iversen CB, TF G (2011) Modeling nanophotothermal therapy: kinetics of thermal ablation of healthy and cancerous cell organelles and gold nanoparticles. 7(2), 137-145. https://doi.org/10.1016/j.nano.2010.06.011

Hadjipanayis CG, Machaidze R, Kaluzova M, Wang L, Schuette AJ (2010) (2010 ) EGFRvIII antibodyconjugated iron oxide nanoparticles for magnetic resonance imaging-guided convection-enhanced delivery and targeted therapy of glioblastoma. 70(15), 6303-6312. https://doi.org/10.1158/0008-5472.can-10-1022

Khlebtsov N, L. D (2011) Review Biodistribution and toxicity of engineered gold nanoparticles: a review of in vitro and in vivo studies. 40(3), 1647-1671. https://doi.org/10.1039/c0cs00018c

A. Freitas, J. (2005) Current Status of Nanomedicine and Medical Nanorobotics Institute for Molecular Manufacturing, Palo Alto, California, USA. 2, 1-25.

Gao X, Yang L, Petros JA, Marshall FF, Simons JW (2005) Review In vivo molecular and cellular imaging with quantum dots. 16(1), 63-72. https://doi.org/10.1016/j.copbio.2004.11.003

Park JY, Baek MJ, Choi ES, Woo S, Kim JH (2009) Paramagnetic Ultrasmall Gadolinium Oxide Nanoparticles as Advanced T1 MRI Contrast Agent: Account for Large Longitudinal Relaxivity, Optimal Particle Diameter, and In Vivo T1 MR Images. 3(11), 3663-3669. https://doi.org/10.1021/nn900761s

Veiseh O, Sun C, Gunn J, Kohler N, Gabikian P (2005) Optical and MRI Multifunctional Nanoprobe for Targeting Gliomas. 5(6), 1003-1008. https://doi.org/10.1021/nl0502569

Hadjipanayis CG, Machaidze R, Kaluzova M, Wang L, Schuette AJ (2010) EGFRvIII antibodyconjugated iron oxide nanoparticles for magnetic resonance imaging-guided convection-enhanced delivery and targeted therapy of glioblastoma. 70(15), 6303-6312. https://doi.org/10.1158/0008-5472.can-10-1022

Gref R, Lück M, Quellec P, Marchand M, Dellacherie E (2000) 'Stealth' corona-core nanoparticles surface modified by polyethylene glycol (PEG): influences of the corona (PEG chain length and surface density) and of the core composition on phagocytic uptake and plasma protein adsorption. 18(3-4), 301-313. https://doi.org/10.1016/s0927-7765(99)00156-3

Sousa F, Mandal S, Garrovo C, Astolfo A, Bonifacio A (2010) Functionalized gold nanoparticles: a detailed in vivo multimodal microscopic brain distribution study. 2(12), 2826. https://doi.org/10.1039/c0nr00345j

Popovtzer R, Agrawal A, Kotov NA, Popovtzer A, Balter J (2008) (2008 ) Targeted gold nanoparticles enable molecular CT imaging of cancer. 8(12), 4593-4596. https://doi.org/10.1021/nl8029114

Foy SP, Manthe RL, Foy ST, Dimitrijevic S, Krishnamurthy N (2010) (2010 ) Optical imaging and magnetic field targeting of magnetic nanoparticles in tumors. 4(9), 5217-5224. https://doi.org/10.1021/nn101427t

Dyer M, Hinchcliffe M, Watts P, Casille J, Jabbal-Gill I (2002) Nasal delivery of insulin using novel chitosan based formulations: a comparative study in two animal models between simple chitosan formulations and chitosan nanoparticles Pharm Res. 19, 998-1008.